Microbubble Composition and Preparation for High-Frequency Contrast-Enhanced Ultrasound Imaging: In Vitro and In Vivo Evaluation

被引:29
|
作者
Daeichin, Verya [1 ,4 ,5 ]
van Rooij, Tom [1 ]
Skachkov, Ilya [1 ,2 ]
Ergin, Bulent [7 ]
Specht, Patricia A. C. [8 ]
Lima, Alexandre [6 ]
Ince, Can [6 ,7 ]
Bosch, Johan G. [1 ]
van der Steen, Antonius F. W. [1 ,3 ,4 ]
de Jong, Nico [1 ,4 ,5 ]
Kooiman, Klazina [1 ]
机构
[1] Erasmus MC, Ctr Thorax, Dept Biomed Engn, NL-3000 CA Rotterdam, Netherlands
[2] Univ Med Ctr Utrecht, Imaging Div, NL-3508 GA Utrecht, Netherlands
[3] Shenzhen Inst Adv Technol, Shenzhen 518000, Peoples R China
[4] Delft Univ Technol, Lab Acoust Wavefield Imaging, Fac Sci Appl, NL-2628 CJ Delft, Netherlands
[5] Netherlands Heart Inst, NL-3511 EP Utrecht, Netherlands
[6] Erasmus MC, Dept Intens Care Adults, NL-3000 CA Rotterdam, Netherlands
[7] Acad Med Ctr, Dept Translat Physiol, NL-1100 DD Amsterdam, Netherlands
[8] Erasmus MC, Dept Anesthesiol, Lab Expt Anesthesiol, NL-3000 CA Rotterdam, Netherlands
关键词
Contrast agent; contrast-enhanced ultrasound (CEUS) imaging; high-frequency; in vitro; in vivo; microbubble; LIPID-COATED MICROBUBBLES; PHOSPHOLIPID ENCAPSULATED MICROBUBBLES; MICRO-ULTRASOUND; VISCOELASTIC PROPERTIES; TARGETED MICROBUBBLES; SUBHARMONIC RESPONSE; TUMOR ANGIOGENESIS; AGENTS; BEHAVIOR; SIZE;
D O I
10.1109/TUFFC.2016.2640342
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Although high-frequency ultrasound imaging is gaining attention in various applications, hardly any ultrasound contrast agents (UCAs) dedicated to such frequencies (>15 MHz) are available for contrast-enhanced ultrasound (CEUS) imaging. Moreover, the composition of the limited commercially available UCAs for high-frequency CEUS (hfCEUS) is largely unknown, while shell properties have been shown to be an important factor for their performance. The aim of our study was to produce UCAs in-house for hfCEUS. Twelve different UCA formulations A-L were made by either sonication or mechanical agitation. The gas core consisted of C4F10 and the main coating lipid was either 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC; A-F formulation) or 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC; G-L formulation). Mechanical agitation resulted in UCAs with smaller microbubbles (number weighted mean diameter similar to 1 mu m) than sonication (number weighted mean diameter similar to 2 mu m). UCA formulations with similar size distributions but different main lipid components showed that the DPPC-based UCA formulations had higher nonlinear responses at both the fundamental and subharmonic frequencies in vitro for hfCEUS using the Vevo2100 high-frequency preclinical scanner (FUJIFILM VisualSonics, Inc.). In addition, UCA formulations F (DSPC-based) and L (DPPC-based) that were made by mechanical agitation performed similar in vitro to the commercially available TargetReady MicroMarker (FUJIFILM VisualSonics, Inc.). UCA formulation F also performed similar to Target-Ready MicroMarker in vivo in pigs with similar mean contrast intensity within the kidney (n = 7), but formulation L did not. This is likely due to the lower stability of formulation L in vivo. Our study shows that DSPC-based microbubbles produced by mechanical agitation resulted in small microbubbles with high nonlinear responses suitable for hfCEUS imaging.
引用
收藏
页码:555 / 567
页数:13
相关论文
共 50 条
  • [21] Directed prostate biopsies utilizing microflow imaging during microbubble contrast-enhanced ultrasound
    Linden, Robert A.
    Gittens, Paul R.
    Forsberg, Flemming
    Trabulsi, Edouard J.
    Gomella, Leonard G.
    Halpern, Ethan J.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 560 - 560
  • [22] Contrast-enhanced voiding urosonography: in vitro evaluation of a second-generation ultrasound contrast agent for in vivo optimization
    Back, Susan J.
    Edgar, J. Christopher
    Canning, Douglas A.
    Darge, Kassa
    PEDIATRIC RADIOLOGY, 2015, 45 (10) : 1496 - 1505
  • [23] Contrast-enhanced voiding urosonography: in vitro evaluation of a second-generation ultrasound contrast agent for in vivo optimization
    Susan J. Back
    J. Christopher Edgar
    Douglas A. Canning
    Kassa Darge
    Pediatric Radiology, 2015, 45 : 1496 - 1505
  • [24] The Value of Contrast-Enhanced Ultrasound and High-Frequency Ultrasound in Evaluating the Efficacy of Wrist Intervention for Patients With Rheumatoid Arthritis
    Wu, Fan
    He, Yikun
    Guo, Jia
    He, Zheng
    Zhou, Jing
    Gao, Zhiling
    JOURNAL OF CLINICAL ULTRASOUND, 2025,
  • [25] Contrast-Enhanced Ultrasound Fundamentals: The Pharmacodynamics and Pharmacokinetics of Contrast. Basics of Contrast-Enhanced Ultrasound Imaging
    Fontanilla Echeveste, M. T.
    Ripolles Gonzalez, T.
    Aguirre Pascual, E.
    RADIOLOGIA, 2024, 66 : S36 - S50
  • [26] Contrast-enhanced ultrasound imaging in vivo with laser-activated nanodroplets
    Yoon, Heechul
    Yarmoska, Steven K.
    Hannah, Alexander S.
    Yoon, Changhan
    Hallam, Kristina A.
    Emelianov, Stanislav Y.
    MEDICAL PHYSICS, 2017, 44 (07) : 3444 - 3449
  • [27] Contrast-enhanced ultrasound in abdominal imaging
    Carlos Nicolau
    Tomás Ripollés
    Abdominal Imaging, 2012, 37 : 1 - 19
  • [28] Contrast-enhanced ultrasound in abdominal imaging
    Nicolau, Carlos
    Ripolles, Tomas
    ABDOMINAL IMAGING, 2012, 37 (01): : 1 - 19
  • [29] Quantitative Evaluation of the Peripheral Nerve Blood Perfusion with High Frequency Contrast-Enhanced Ultrasound
    Wang, Yuexiang
    Tang, Peifu
    Zhang, Lihai
    Guo, Yizhu
    Wan, Wenbo
    ACADEMIC RADIOLOGY, 2010, 17 (12) : 1492 - 1497
  • [30] Comparison of bolus and infusion of microbubble contrast agent for contrast-enhanced liver ultrasound
    Okada, M
    Albrecht, T
    Hoffmann, CW
    Wolf, K
    RADIOLOGY, 2001, 221 : 324 - 325